← All medicines
AirFluSal MDI 25 microgram/125 microgram/dose pressurised inhalation, suspension
Licence PA0711/270/001 · Not marketed
- Licence holder
- Rowex Limited, (all products →)
- Active substances
- SALMETEROL XINAFOATE, Fluticasone propionate
- Dosage form
- Pressurised inhalation, suspension
- Route of administration
- Inhalation use
- ATC codes
- R03AK, R03AK06
- First authorised
- 12/05/2017
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Hybrid application (Article 10(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.